MyoBridge Volunteer
Donor Program
High-quality muscle tissue and primary cells from precisely defined donor groups. Simplify your cell sourcing, limit variables, and access unrivalled characterization.
Streamline tissue sourcing. Accelerate research.
The MyoBridge Volunteer Donor Program is a tissue sourcing program that connects researchers with human muscle samples donated by real-world participant populations stratified by age, disease, or other demographics.
Our donor network, IRB-approved tissue collection protocols, and muscle cell expertise allow us to meet your precise needs so you can eliminate tissue sourcing hurdles and focus on your research.
How MyoBridge works
- Exploratory Call: Establish deliverables, best approach, and unique considerations.
- Study Design: We determine the appropriate IRB-approved protocol for the tissue collection study.
- Tissue Procurement: Our clinical partners recruit the appropriate donors and execute the tissue collection study with support from our experts.
- Processing: Tissue is processed according to your specifications, including quality testing and any requested analytical services.
- Delivery: Samples are shipped via reliable cold-chain logistics to any location worldwide.
Reliable sourcing from world-leading muscle cell experts
Ethical Sourcing
MyoBridge tissue collection studies are IRB-approved and run according to strict clinical study protocols.
End-to-end service
Just tell us what you need. We'll handle the rest, from recruiting donors to delivering ready-to-use tissue samples to your laboratory.
Proven Quality
All Custom Cell Solutions products are backed by over two decades of muscle cell expertise and widespread use in published scientific research.
FEATURED
Curi Bio and Cook MyoSite Announce Strategic Scientific Collaboration to Advance Translational Human Muscle Disease Models
Curi Bio, the global leader in human 3D engineered tissue platforms, and Cook MyoSite, a pioneer in the development of skeletal muscle-based therapies, announced a strategic partnership to develop advanced, predictive human engineered tissue models aimed at addressing muscle-related diseases and metabolic disorders, including obesity and diabetes.
